Kazuma Yamakawa Selected Research

Length of Stay

10/2023	Short-term Outcomes of Laparoscopic and Open Distal Pancreatectomy Using Propensity Score Analysis: A Real-world Retrospective Cohort Study.
8/2021	Association of frailty on treatment outcomes among patients with suspected infection treated at emergency departments.
1/2021	Hyperoxemia during resuscitation of trauma patients and increased intensive care unit length of stay: inverse probability of treatment weighting analysis.
10/2020	Time Trends of the Outcomes and Treatment Options for Disseminated Intravascular Coagulation: A Nationwide Observational Study in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuma Yamakawa Research Topics

Disease

74	Sepsis (Septicemia) 05/2024 - 01/2011
54	Disseminated Intravascular Coagulation 05/2024 - 01/2011
21	Wounds and Injuries (Trauma) 01/2023 - 05/2011
17	Septic Shock (Toxic Shock Syndrome) 01/2023 - 01/2016
16	Hemorrhage 01/2024 - 04/2013
15	Thrombosis (Thrombus) 11/2023 - 01/2011
14	COVID-19 01/2024 - 09/2020
10	Infections 01/2024 - 11/2011
10	Critical Illness (Critically Ill) 12/2023 - 06/2015
8	Inflammation (Inflammations) 01/2023 - 06/2012
6	Pneumonia (Pneumonitis) 03/2024 - 05/2011
5	Neoplasms (Cancer) 10/2023 - 09/2020
5	Multiple Organ Failure (MODS) 01/2022 - 06/2012
4	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 05/2024 - 07/2015
3	Burns 01/2023 - 01/2021
3	Ventilator-Associated Pneumonia 01/2022 - 01/2017
2	Out-of-Hospital Cardiac Arrest 05/2024 - 01/2020
2	postintensive care syndrome 01/2024 - 09/2022
2	Lung Diseases (Lung Disease) 08/2023 - 05/2011
2	Communicable Diseases (Infectious Diseases) 01/2022 - 01/2017
2	Shock 01/2022 - 01/2021
2	Muscular Diseases (Myopathy) 01/2021 - 01/2020
2	Leukemia 10/2020 - 10/2020
2	Crush Injuries 12/2016 - 06/2012
1	Rib Fractures (Rib Fracture) 03/2024
1	Pathologic Processes 01/2024
1	Hematologic Neoplasms (Hematological Malignancy) 01/2024
1	Hyperoxia 12/2023
1	Thrombocytopenia (Thrombopenia) 11/2023
1	Ventricular Fibrillation 11/2023
1	Ileus 10/2023
1	Hyperlactatemia 01/2023
1	Post-Cardiac Arrest Syndrome 01/2023
1	Cholangitis 01/2023
1	Heart Arrest (Cardiac Arrest) 01/2023

Drug/Important Bio-Agent (IBA)

53	Dacarbazine (DIC)FDA LinkGeneric 05/2024 - 01/2011
23	AnticoagulantsIBA 05/2024 - 01/2011
17	ThrombomodulinIBA 01/2024 - 01/2011
15	AntithrombinsIBA 01/2024 - 01/2016
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2013
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 11/2011
6	Oxygen (Dioxygen)IBA 12/2023 - 01/2021
5	FibrinIBA 04/2024 - 09/2020
5	Fibrinogen (Factor I)FDA Link 04/2024 - 02/2019
4	fibrin fragment D (D-dimer)IBA 04/2024 - 02/2019
4	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2012
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023 - 01/2021
4	Tranexamic Acid (AMCA)FDA Link 08/2022 - 01/2017
3	SteroidsIBA 12/2023 - 11/2011
3	EndotoxinsIBA 01/2023 - 06/2013
3	Heparin (Liquaemin)FDA LinkGeneric 01/2023 - 01/2016
3	Polymyxin B (Aerosporin)FDA LinkGeneric 01/2023 - 04/2017
3	Histones (Histone)IBA 08/2022 - 01/2016
3	tocilizumab (atlizumab)FDA Link 01/2022 - 01/2021
3	remdesivirIBA 01/2022 - 01/2021
3	Coloring Agents (Dyes)IBA 01/2022 - 01/2017
3	favipiravirIBA 01/2022 - 01/2021
2	formycin diphosphate (FDP)IBA 04/2024 - 01/2021
2	antithrombin III-protease complexIBA 04/2024 - 09/2020
2	LipopolysaccharidesIBA 01/2024 - 06/2013
2	Indicators and Reagents (Reagents)IBA 08/2023 - 12/2021
2	InterleukinsIBA 01/2023 - 01/2016
2	Vasopressins (Vasopressin)IBA 01/2023 - 01/2021
2	Protein CIBA 01/2023 - 11/2019
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023 - 01/2021
2	HMGB1 Protein (HMG1)IBA 06/2022 - 06/2012
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2021
2	baricitinibIBA 01/2022 - 01/2021
2	Thrombin FDA Link 01/2022 - 01/2020
2	casirivimab and imdevimab drug combinationIBA 01/2022 - 01/2021
2	ConnectinIBA 01/2021 - 01/2020
2	Hemostatics (Antihemorrhagics)IBA 09/2020 - 03/2016
2	Plasminogen Activators (Plasminogen Activator)IBA 09/2020 - 01/2020
2	ProcalcitoninIBA 01/2019 - 01/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 06/2012
2	Receptor for Advanced Glycation End ProductsIBA 01/2017 - 06/2012
1	Fibrin Fibrinogen Degradation ProductsIBA 04/2024
1	prothrombin fragment 1IBA 04/2024
1	MutagensIBA 01/2024
1	ciclesonide FDA Link 12/2023
1	tetraethylpyrazine (TEP)IBA 11/2023
1	A-factor (Streptomyces)IBA 03/2023
1	beta Lactam AntibioticsIBA 01/2023

Therapy/Procedure

37	Therapeutics 05/2024 - 01/2011
14	Critical Care (Surgical Intensive Care) 05/2024 - 05/2011
11	Resuscitation 11/2023 - 01/2017
9	Artificial Respiration (Mechanical Ventilation) 03/2024 - 01/2021
6	Mechanical Ventilators (Ventilator) 01/2022 - 05/2012
4	Length of Stay 10/2023 - 10/2020
3	Intravenous Administration 01/2023 - 06/2012
2	Nutrition Therapy (Medical Nutrition Therapy) 01/2024 - 01/2022
2	Blood Transfusion (Blood Transfusions) 08/2022 - 03/2021
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 01/2020
2	Punctures 01/2022 - 01/2022
2	Patient Care Bundles 01/2022 - 11/2019
2	Ligation 01/2022 - 01/2022
2	Hemoperfusion 11/2020 - 04/2017
2	Patient Transfer (Patient Dumping) 01/2019 - 01/2018
1	Conservative Treatment 03/2024
1	Pancreatectomy 10/2023